All posts tagged
AstraZeneca Teams Up with German Biotech to Develop mRNA Therapy
AstraZeneca and MSD Expand Use of Oral Ovarian Cancer Drug
AstraZeneca’s Checkpoint Inhibitor Scores a Win in Lung Cancer After Last Week’s Failure
AstraZeneca Misses Endpoint in Big Checkpoint Inhibitor Combo Trial
AstraZeneca Misses the Mark in Late-Stage Asthma Trial
More News! AstraZeneca’s €2B Blowout & First Checkpoint Inhibitor
Unexpected Side Effects: Are we Ready for the Rise of Immunotherapies?
Heptares Finds New GPCR Target to Treat Pain, Cancer and Inflammation
How is Biotech Transforming Pharma’s R&D Model?
Heptares Takes Home €11M for its Next-Generation Checkpoint Inhibitor
You Can Now Search Worldwide Genomic Data in a Single Platform
Can this British Biotech Overcome Failure buying drugs from AstraZeneca?
Labiotech UG, All Rights Reserved -
Send this to friend